HOTH
Hoth Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$13.20M
P/E Ratio
—
EPS
$-0.80
Beta
0.58
52W High
$2.12
52W Low
$0.49
50-Day MA
$0.73
200-Day MA
$1.11
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Hoth Therapeutics Inc
Hoth Therapeutics, Inc., a biopharmaceutical company, is focused on developing therapies for dermatological disorders. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-14.10M |
| Operating Margin | 0.00% |
| Return on Equity | -191.40% |
| Return on Assets | -100.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.40 |
| Price-to-Book | 3.17 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $19.13M |
| Float | $15.79M |
| % Insiders | 2.89% |
| % Institutions | 4.11% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026